Court restricts U.S. abortion access, blocks mailing of mifepristone pill

Posted May 1, 2026 6:19 pm Updated May 1, 2026 6:21 pm 1 min read 5:19 U.S. Supreme Court rules abortion drug Mifepristone will remain widely accessible RELATED: U.S. Supreme Court rules abortion drug Mifepristone will remain widely accessible – Jun 13, 2024 A U.S. appeals court has restricted access to one of the most common means of abortion in the U.S. by blocking mailing of prescriptions of mifepristone. A panel of the New Orleans-based 5th U.S. Circuit Court of Appeals is requiring that the abortion pill be distributed only in-person at clinics.“Every abortion facilitated by FDA’s action cancels Louisiana’s ban on medical abortions and undermines its policy that ‘every unborn child is human being from the moment of conception and is, therefore, a legal person,’” the ruling states.Judges have long deferred to the FDA’s judgments on the safety and appropriate regulation of drugs.FDA officials under President Donald Trump have repeatedly stated the agency is conducting a new review of mifepristone’s safety, at the direction of the president. Story continues below advertisement The judges noted in their ruling that FDA “could not say when that review might be complete and admitted it was still collecting data.” Get weekly health news